From The Editor | April 24, 2020

An Interview With Miguel Forte, CEO, Bone Therapeutics


By Erin Harris, Editor-In-Chief, Cell & Gene
Follow Me On Twitter @ErinHarris_1

Bone Therapeutics has received regulatory approvals for its clinical trial applications for the next studies of both its lead candidates. In this video, Miguel Forte, CEO of Bone Therapeutics and I talk about the significance of these two studies, his work with ARM and ISCT, as well as COVID-19’s impact on the cell and gene sector.